To hear about similar clinical trials, please enter your email below
Trial Title:
Mindfulness-based Virtual Reality Intervention
NCT ID:
NCT05602051
Condition:
Hematologic Neoplasms
Conditions: Official terms:
Neoplasms
Hematologic Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Unknown status
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
Single (Outcomes Assessor)
Intervention:
Intervention type:
Device
Intervention name:
virtual reality device
Description:
mindfulness combined with virtual reality
Arm group label:
Virtual reality+Mindfulness
Other name:
Mindfulness
Summary:
Through virtual reality technology and mindfulness therapy, we can intervene the patients
with Hematologic Neoplasms during chemotherapy, hoping to improve their symptoms and
self-efficacy.
Detailed description:
In recent years, the intervention method of giving mindfulness has achieved good results
in the management of symptoms related to cancer patients, but the compliance of patients
with conventional mindfulness intervention is low. The virtual reality intervention based
on mindfulness can effectively mobilize the enthusiasm of patients to participate in
research and the compliance of mindfulness training. We aim to combine virtual reality
with mindfulness intervention to intervene patients with hematologic neoplasms during
chemotherapy, To improve their symptoms.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Clinical diagnosis of Hematologic Neoplasms(leukemia, lymphoma or multiple myeloma)
and receiving chemotherapy
- Hospitalized for more than 4 weeks
- Have normal communication ability, clear consciousness, and willing to participate
in this study
Exclusion Criteria:
- People are cognitive dysfunction and audio-visual dysfunction
- Have mental problems or have reported mental disorders
Gender:
All
Minimum age:
18 Years
Maximum age:
85 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
the First Affiliated Hospital of Nanjing Medical University
Address:
City:
Nanjing
Country:
China
Status:
Recruiting
Contact:
Last name:
yuxi Zhang
Phone:
13584031657
Email:
zhangyuxi830@163.com
Start date:
November 1, 2021
Completion date:
December 1, 2022
Lead sponsor:
Agency:
Nanjing University of Traditional Chinese Medicine
Agency class:
Other
Source:
Nanjing University of Traditional Chinese Medicine
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05602051
